Particularly, HZ compounds accumulate cancer cells, including leukemic cells, in S-phase, increase TP53 synthesis, and synergize with an inhibitor of TP53 degradation to reduce tumor growth in vivo [218]. The gene discussed is TP53; the disease is cancer.